Capital Analysts LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25K Hold
446
﹤0.01% 1077
2025
Q4
$27K Hold
446
﹤0.01% 1043
2025
Q3
$24K Hold
446
﹤0.01% 1030
2025
Q2
$25K Hold
446
﹤0.01% 956
2025
Q1
$32K Sell
446
-71
-14% -$4.78K ﹤0.01% 879
2024
Q4
$34K Hold
517
﹤0.01% 827
2024
Q3
$36K Sell
517
-243
-32% -$20.3K ﹤0.01% 789
2024
Q2
$63K Sell
760
-135
-15% -$11.2K ﹤0.01% 659
2024
Q1
$78K Hold
895
﹤0.01% 588
2023
Q4
$86K Sell
895
-105
-11% -$9.29K ﹤0.01% 555
2023
Q3
$88K Buy
1,000
+121
+14% +$10.8K ﹤0.01% 506
2023
Q2
$76K Hold
879
﹤0.01% 515
2023
Q1
$85K Hold
879
﹤0.01% 497
2022
Q4
$91K Hold
879
0.01% 519
2022
Q3
$75K Hold
879
0.01% 492
2022
Q2
$73K Hold
879
0.01% 484
2022
Q1
$68K Sell
879
-65
-7% -$5.44K ﹤0.01% 504
2021
Q4
$83K Buy
+944
New +$77.9K 0.01% 480
2019
Q3
Sell
-25
Closed -$2K 699
2019
Q2
$2K Buy
+25
New +$2.14K ﹤0.01% 628

Other funds holding BMRN